Complexes with biologically active ligands. Part 10 inhibition of carbonic anhydrase isozymes I and II with metal complexes of imidazo[2,1-b]-1,3,4- thiadiazole-2-sulfonamide

Metal-Based Drugs

Volumn 4, Issue 1, 1997, Pages 19-26

  Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CARBONATE DEHYDRATASE INHIBITOR; COBALT; COPPER; FERRIC ION; IMIDAZO[2,1 B] 1,3,4 THIADIAZOLE 2 SULFONAMIDE; IMIDAZO[2,1 B]BENZOTHIAZOLE DERIVATIVE; LIGAND; MERCURY; METAL COMPLEX; NICKEL; SILVER; UNCLASSIFIED DRUG; VANADIUM; ZINC;

ARTICLE; BRAIN BLOOD VESSEL; COMPLEX FORMATION; ELECTRON SPIN RESONANCE; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; VASODILATATION;

EID: 0030946132     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1997.19     Document Type: Article

References (51)

1. Preceding part: A. Jitianu, M.A. Hies, F. Briganti, A. Scozzafava, C.T. Supuran, Metal Based Drugs., 1997, 4, 1-8.
2. a) C.T. Supuran, "Carbonic anhydrase inhibitors", in "Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism", I. Puscas Ed., Helicon, Timisoara 1994, pp. 29-111;
3. b) I. Puscas, C.T. Supuran, "Farmacologia clinica da ulcera peptica" in "Aparelho Digestivo", J. Coelho Ed., MEDSI, Rio de Janeiro, 1996, pp. 1704-1734;
4. T.H. Maren, Pharmacol.Rev., 1967, 47, 595-782;
5. T.H. Maren, J. Glaucoma, 1995, 4, 49-62.
6. E.B. Larson, R.C. Roach, R.B. Schoene, T.F. Hornbein, JAMA, 1982, 248, 328-332.
7. D. Hewett-Emmett, R.E. Tashian, Mol.Phylogenet.Evol., 1996, 5, 50-77.
8. C.T. Supuran, Roum.Chem.Quart.Rev., 1993, I, 77-116.
9. a) I.T. Barnish, P.E. Cross, R.P. Dickinson, B. Gadsby, M.J. Parry, M.J. Randall, I.W. Sinclair, J.Med. Chem., 1980, 25, 117-121;
10. b) P.E. Cross, B. Gadsby, G.F. Holland, W.M. McLamore, J.Med.Chem., 1978, 27, 845-851.
11. a) G.D. Hartmann, W. Halczenko, Heterocycles, 1989, 29, 1943-1949;
12. b) O.W. Waltersdorf, H. Schwam, J.B. Bicking, S.J. Solms, D.R. Fishman, S.L. Graham, P. Gautheron, J.M. Hoffman, R.D. Larsson, W.S. Lee, S.R. Michelson, CM. Robb, N.N. Share, K.L. Shepard, A.M. Smith, J.M. Sondey, K.M. Strohmaier, M.F. Sugrue, M.P. Viader, J.MedChem., 1989, 32, 2486-2492;
13. S.L. Graham, K.L. Shepard, P.S. Anderson, J.J. Baldwin, D.B. Best, M.E. Christy, M.B. Freedman, P. Gautheron, C.N. Habecker, J.M. Hoffman, P.A. Lyle, S.R. Michelson, G.S. Ponticello, CM. Robb, H. Schwam, A.M. Smith, R.L. Smith, J.M. Sondey, K.M. Strohmaier, M.F. Sugrue, S.L. Varga, J.Med.Chem., 1989, 32, 2548-2554;
14. S.L. Graham, J.M. Hoffman, P. Gautheron, S.R. Michelson, T.H. Scholz, H. Schwam, K.L. Shepard, A.M. Smith, J.M. Sondey, M.F. Sugrue, R.L. Smith, J.Med.Chem., 1990, 33, 794-799.
15. a) J.D. Prugh, G.D. Hartmann, P.J. Mallorga, B.M. McKeever, S.R. Michelson, M.A. Murcko, H. Schwam, R.L. Smith, J.M. Sondey, J.B. Springer, M.F. Sugrue, J.Med.Chem., 1991, 34, 1805-1818;
16. b) T.J. Blacklock, P. Sohar, J.W. Butcher, T. Lamanec, E.J.J. Grabowski, J.Org.Chem., 1993, 58, 1672-1679;
17. C. A. Hunt, P.J. Mallorga, S.R. Michelson, H. Schwam, J.M. Sondey, R.L. Smith, M.F. Sugrue, K.L. Shepard J.MedChem., 1994, 37, 240-247.
18. a) G. Alzuet, S. Ferrer, J. Borras, C.T. Supuran, Roum.Chem.Quart.Rev., 1994, 2, 283-300;
19. b) C.T. Supuran, R. Stefan, G. Manole, I. Puscas, M. Andruh, Rev.Roum.Chim., 1991, 36, 1175-1179;
20. C.T. Supuran, G. Manole, M. Andruh, J.Inorg.Biochem., 1993, 49, 97-103;
21. C.T. Supuran, Rev.Roum.Chim., 1992, 37, 849-855;
22. e) C.T. Supuran, M. Andruh, Rev.Roum.Chim., 1994, 39, 1229-1234.
23. a) C.T. Supuran, Rev.Roum.Chim., 1993,38, 229-236;
24. b) S.L. Sumalan, J. Casanova, G. Alzuet, J. Borras, A. Castiñeiras, C.T. Supuran, J.Inorg.Biochem., 1996, 62, 31-39;
25. C.T. Supuran, G.L. Almajan, Main Group Met. Chem., 1995, 18, 347-351;
26. C.T. Supuran, Metal Based Drugs, 1995, 2, 327-330;
27. e) C.T. Supuran, Metal Based Drugs, 1995, 2, 331-336;
28. f) J. Borras, T. Cristea, C.T. Supuran, Main Group Met. Chem., 1996, 19, 339-346;
29. g) J. Borras, J. Casanova, T. Cristea, A. Gheorghe, A. Scozzafava, C.T. Supuran, V. Tudor, Metal Based Drugs, 1996, 3, 143-148.
30. R.S. Drago, in "Physical Methods in Chemistry", W.B. Saunders & Co., London, 1977, p. 411.
31. a) C. Forsman, G. Behravan, A. Osterman, B.H. Jonsson, Acta Chem. Scand., 1988, B42, 314-318;
32. b) G. Behravan, P. Jonasson, B.H. Jonsson, S. Lindskog, Eur.JBiochem., 1991, 198, 589-592.
33. R.G. Khalifah, D.J. Strader, S.H. Bryant, S.M. Gibson, Biochemistry, 1977, 16, 2241-2247.
34. a) P.O. Nyman, S. Lindskog, Biochim.Biophys.Acta, 1964,55, 141-151;
35. b) L.E. Henderson, D. Henriksson, P.O. Nyman, J.Biol.Chem., 1976, 251, 5457-5463.
36. Y. Pocker, J.T. Stone, Biochemistry, 1967, 6, 668-679.
37. a) C.T. Supuran, A. Nicolae, A. Popescu, Eur.J. Med.Chem., 1996, 31, 431-438;
38. b) C.T. Supuran, A. Popescu, M. Ilisiu, A. Costandache, M.D. Banciu, Eur.J.Med.Chem., 1996, 31, 439-447;
39. C.T. Supuran, A. Scozzafava, A. Popescu, R. Bobes-Tureac, A. Banciu, A. Creanga, G. Bobes-Tureac, M.D. Banciu, Eur.J.Med.Chem., 1997, 32, (in press).
40. C.J. Balhausen, H. Gray, Inorg.Chem., 1962,1, 111-115.
41. A.B.P. Lever, "Inorganic Electronic Spectroscopy", 2nd Edition, Elsevier, Amsterdam, 1984, pp. 135-138.
42. L. Banci, A. Bencini, C. Benelli, D. Gatteschi, C. Zanchini, Struct.Bonding, 1982, 52, 37-79.
43. L. Sacconi, F. Mani, A. Bencini, "Nickel", in "Comprehensive Coordination Chemistry", G. Wilkinson, R. Gillard and J. McCleverty Eds., Pergamon Press, Oxford, 1987, Vol. 5, pp. 1-347.
44. a) D.W. Smith, Struct.Bonding, 1978, 35, 88-117;
45. b) C.T. Supuran, C.I. Lepadatu, R. Olar, A. Meghea M. Brezeanu, Rev.Roum.Chim., 1993, 38, 1509-1517;
46. S. Ferrer, J.G. Haasnoot, R.A.G. de Graaf, J. Reedijk, J. Borras, Inorg.Chim.Acta, 1992,192, 129-133;
47. C.T. Supuran, Metal Based Drugs, 1996, 3, 79-83.
48. A. Bult, Met. Ions Biol. Syst., 1983, 16, 261-268.
49. F.J. Philpot, J.L. Philpot, Biochem. J., 1936, 30, 2191-3003.
50. a) M. Coltau, I. Puscas, C.T. Supuran, "Angiotensin II stimulates the activity of carbonic anhydrase I while administration of angiotensin converting enzyme inhibitors reduces the activity of isozyme CA I", in "Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism", I. Puscas Ed., Helicon, Timisoara 1994, pp. 273-275;
51. b) I. Puscas, M. Coltau, I.C Puscas, C.T. Supuran, Rev.Roum.Chim., 1994, 39, 237-242.